Serum osteoprotegerin and RANKL are not specifically altered in women with postmenopausal osteoporosis treated with teriparatide or risedronate: a randomized, controlled trial (Q46753882)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q37828402)
(P304) 281-285
(P433) 4
(P478) 40
(P577) Friday, February 15, 2008
(P921) (Q165328)
(Q55950294)
(P1433) (Q15758682)
(P1476) "Serum osteoprotegerin and RANKL are not specifically altered in women with postmenopausal osteoporosis treated with teriparatide or risedronate: a randomized, controlled trial" (language: en)
(P2093) A D Anastasilakis
D G Goulis
S Gerou
G Koukoulis
M Kita
A Avramidis
other details
description scientific article

External Links